Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2009

BG Medicine, NHLBI, and Boston University Partner for Cardiovascular Biomarker Discovery

  • BG Medicine, the National Heart, Lung, and Blood Institute (NHLBI), and Boston University (BU) will jointly undertake biomarker discovery studies for heart disease and early detection of metabolic syndrome.

    Under this CRADA, BG Medicine's technology will be used to analyze biosamples obtained during years of collection by Framingham Heart Study researchers. The Framingham Heart Study is funded by NHLBI and conducted in collaboration with BU's School of Medicine and School of Public Health.

    Only information from participants who have consented to sharing their specimens and data with commercial researchers will be used, and all shared information will be de-identified to protect participants' privacy.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »